Using biochemical and structural analyses we have investigated the catalytic mechanism of the recently discovered flavin-dependent thymidylate synthase ThyX from Paramecium bursaria chlorella virus-1 (PBCV-1). Site-directed mutagenesis experiments have identified several residues implicated in either NADPH oxidation or deprotonation activity of PBCV-1 ThyX. Chemical modification by DEPC and mass spectroscopic analyses identified a histidine residue (H53), crucial for NADPH oxidation and located in the vicinity of the redox active N5 atom of the FAD ring system. Moreover, we observed that the conformation of active site key residues of PBCV-1 ThyX differs from earlier reported ThyX structures, suggesting structural changes during catalysis. Steady-state kinetic analyses support a reaction mechanism where ThyX catalysis proceeds via formation of distinct ternary complexes without formation of a methyl-enzyme intermediate.
All cellular organisms need thymidylate (deoxythymidine 5'-monophosphate or dTMP) for the replication of their chromosomes, as Abbreviations used: DEPC, diethylpyro-carbonate; MALDI-TOF MS, matrix assisted laser desorption ionization-time of flight mass spectrometry; r.m.s.d., root-mean-square distance dTMP is required for the biosynthesis of deoxythymidine 5'-triphosphate (dTTP), a building block of DNA. Cells can produce thymidylate either de novo from deoxyuridine 5'-monophosphate (dUMP) or incorporate thymidine using thymidine kinase (Tdk). The de novo pathway of dTMP synthesis requires a specific enzyme, thymidylate synthase, which methylates dUMP at position 5 of the pyrimidine ring. Two structurally and mechanistically distinct classes of thymidylate synthases exist. The well-studied ThyA proteins (EC 2.1.1.45) catalyse the reductive methylation reaction of dUMP, with methylenetetrahydrofolate (CH 2 H 4 folate) serving as one-carbon donor and as source of reductive power [reviewed in (1) ].
On the other hand, the recently discovered ThyX (E.C. 2.1.1.148) family of thymidylate synthases contains flavin adenine dinucleotide (FAD) (2) that is tightly bound by a novel fold (3) . FAD mediates hydride transfer from reduced nicotinamide (NADPH) during catalysis (4) (5) (6) . Consequently, in the reaction catalysed by ThyX, CH 2 H 4 folate serves only as carbon donor, leading to the prediction that H 4 folate (and not H 2 folate as is the case for ThyA) is produced (2) . This prediction has recently been confirmed by identifying H 4 folate as a reaction product of Chlamydia trachomatis ThyX using high pressure liquid chromatography (7).
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The catalytic reaction of thymidylate synthase ThyA is a sequential ordered mechanism in which dUMP binding is followed by the entry of CH 2 H 4 folate and subsequent ternary complex formation with dUMP and CH 2 H 4 folate simultaneously bound to the enzyme (8, 9) . This was demonstrated by thorough steady-state kinetic measurements using varying concentrations of these two substrates of the ThyA reaction. Moreover, using F-dUMP in the reaction mixtures, this covalent ternary complex can readily be trapped for ThyA proteins (10) . Although ThyX catalysis is of considerable interest for detecting and designing new anti-microbial compounds (2) , our understanding of the reaction mechanism of this enzyme is still incomplete. Several models propose that the catalytic cascade of different ThyX proteins starts with oxidation of NADPH (4-6), a reaction step that does not occur during ThyA catalysis. We have proposed earlier that Paramecium bursaria chlorella virus-1 (PBCV-1) ThyX uses a reaction mechanism with the formation of a ternary complex of CH 2 H 4 folate and dUMP bound to the enzyme (6) . This proposal is compatible with a structural model where dUMP and CH 2 H 4 folate are simultaneously docked at the active site of ThyX from Thermotoga maritima (4) . However, a ping-pong mechanism involving the formation of a methyl-enzyme as reaction intermediate has been proposed for Chlamydia trachomatis ThyX proteins (7). FdUMP does not seem to form a covalent intermediate with ThyX enzymes (11) , complicating analysis of the ThyX reaction. Consequently, it is currently unknown whether this discrepancy results from experimental differences or rather indicates that ThyX proteins from viral and cellular sources might use different reaction mechanisms.
The goal of this work is to obtain detailed insight into the enzymatic mechanism of the highly active PBCV-1 ThyX protein using a combination of biochemical and structural approaches. We therefore identified and further investigated several residues required for substrate binding and/or catalysis of PBCV-1 ThyX. Moreover, we report the crystal structure of the PBCV-1 ThyX tetramer that provides a structural basis for the interpretation of the obtained functional data. We observed that the conformation of active site key residues of PBCV-1 ThyX is different from earlier reported ThyX structures, suggesting that the active site undergoes structural changes during catalysis. Our detailed steadystate kinetic analyses continue to indicate that ThyX uses a reaction mechanism where catalysis proceeds via formation of distinct ternary complexes. Complementation tests were performed as described previously (11) .
EXPERIMENTAL PROCEDURES

Molecular
genetic techniques and construction of plasmids -The pVEX plasmid containing the thyX gene from PBCV-1 is a pGEX-2T derivative that has been described previously (6) . Site-directed mutations were introduced using the Quik Change mutagenesis kit (Stratagene) with pVEX (T7tag-a674r6His) as template using the following primer couples (all sequences are indicated in 5' to 3' direction):
(CCACAAGCATGGTCAATC) and (CATAGGCGGTGTTCGTAACC) for H53Q, (CCACAAGAAGTGGTCAATC) and (CATAGGCGGTGTTCTTCACC) for H53K (CGCCAGCGGAGCTTCCACTTC) and (CGAGTCCAAGAAGCGGTCGCC) for H79Q, (CGCAAGCGGAGCTTCCACTTC) and (GTCCAAGAAGCGTTCGCCTCG) for H79K, (CAGGCGTACGCATCTGTGATG) and (CGTACGCCTGGGAAAATTCCT) for R90A, (GGATCCAGTACATCGAACTGC) and (CCCTAACCTAGGTCATGTAGC) for H177Q, (GGATCAAGTACATCGAACTGC) and (CCCTAACCTAGTTCATGTAGC) for H177K, (CGAACTGG CGACTTCAAACGG) and (GCTTGACCGCTGAAGTTTGCC) for R182A. The E190G substitution was obtained as described earlier (6) .
Protein expression and purification -The PBCV-1 wild-type and mutant ThyX proteins were expressed in either E. coli DH5α (∆thyA) or BL21 at 37°C in 800 ml LB medium containing 100 µg/ml ampicillin. Protein expression was induced by adding 1 mM IPTG to early exponential phase cultures (O.D.600 ˜ 0.5) for 3 hours. His-tagged proteins were purified from cell-free extracts by gravity-flow chromatography on Ni-NTA agarose (Qiagen) and gel filtration using an S-200 column (Amersham). Eluted proteins were stored at -80°C in 50 mM N-(2 hydroxethyl)piperazine-N'-2-ethanesulfonic acid (HEPES), pH 7.0, supplemented with 10% glycerol. Protein samples were analyzed on 12.5% SDS PAGE and were more than 95% pure.
ThyX activity measurements -Tritium release assays for measuring PBCV-1 ThyX activity in vitro were performed essentially as described earlier for the Helicobacter pylori ThyX protein (11) with 37.5 pmoles of enzyme in 25 µL reaction mixture. Reactions were terminated after 3.5 min incubation. Kinetic parameters were determined using non-linear regression using the software package GRAPHPAD. Typical reactions contained 10 mM MgCl 2 , 0.5 mM NADPH, 60 µM FAD, 500µM CH 2 H 4 folate, 12.5µM dUMP, 10% glycerol in 50 mM HEPES, pH 7.5. The specific activity of the [5- 3 H]-dUMP stock (Moravek) used in the experiments was 13.6 Ci/mmol. Activities of mutant proteins analysed were compared with those of wildtype protein obtained in parallel experiments.
In double titration experiments, the concentrations of dUMP and CH 2 H 4 folate were varied from 3 to 50 µM and from 3 to 100 µM, respectively; CH 2 H 4 folate and NADPH were varied from 3 to 100 µM and from 100 to 300 µM respectively, and the concentrations of dUMP and NADPH were varied from 3 to 100 µM and from 6.25 to 200 µM respectively. Where indicated, deprotonation assays were also performed using enzyme treated with diethyl-pyrocarbonate (see below).
NADPH oxidation activity of ThyX proteins was measured using a total volume of 100 µl. Reaction components were 50 µM dUMP, 10% glycerol, 1 mM MgCl 2 , 400 µM NADPH, 10 µM FAD. Control experiments established that the addition of 50 µM of CH 2 H 4 folate substantially inhibited NADHP oxidation activity. Activity was monitored by net decrease of absorbance at 340 nm using a CARY 50 spectrophotometer (Varian). An extinction coefficient of 6400 cm -1 at 340 nm (ε 340 ) was used to quantify absorption changes. Note that this assay is different from the spectrophotometric assay established for ThyA proteins that catalyze the oxidation of H 4 folate to H 2 folate resulting in net increase in absorption at 340 nm. Fluorescence detection measurements of oxidation activity were performed at 340 nm excitation and 460 nm emission, using a Chameleon II multi-label plate reader (Hidex Oy, Finland). Under these experimental conditions, non-modified PBCV-1 enzyme decreased fluorescence intensity 1250 arbitrary units/min (corresponding to 100% indicated in Table 2 ) whereas the activity of DEPC-treated enzyme was not detectable.
Chemical modification of PBCV-1 ThyX with diethyl pyrocarbonate (DEPC) and reversal of reaction with hydroxylamine -DEPC has been used to analyze the functional role of histidine residues in a number of proteins, although under certain conditions non-specific reactions with serine and threonine residues can occur. In the presence of DEPC, histidine residues yield an N-carbethoxy-histidyl derivative that is reversible upon addition of hydroxylamine (NH 2 OH). In the experiments shown, DEPC was freshly diluted with absolute ethanol before each use. Its concentration was determined by reaction with imidazole as described (13) . Modification of PBCV-1 ThyX was performed at 25°C for 20 min in 980 µL final volume containing 15 µM PBCV-1 ThyX wild type protein (15 nmoles), 50 mM potassium phosphate buffer pH 7.0 and 250 µM DEPC (the final concentration of ethanol never exceeded 3% (v/v)). A control experiment was performed under the same conditions without DEPC. 54 µL of 1 M hydroxylamine hydrochloride (adjusted to pH 7.0) were added to 490 µL of DEPC-treated PBCV-1 ThyX WT and control solutions, and the reaction was carried out at 25°C for 20 min. DEPC and hydroxylamine were removed by size exclusion chromatography using a 5 mL Sephadex G-25 desalting column (Amersham Bioscience) equilibrated in 50 mM potassium phosphate buffer pH 7.0. Samples were routinely concentrated to 80 µL in a Microcon YM10 concentrator (Amicon) before proteolytic digestion and mass spectrometry.
Proteolytic digestion and MALDI-TOF mass spectrometry -1 µL of trypsin (1mg/mL) was added to 15 µL (~1 nmole) of concentrated control protein and DEPC-inactivated ThyX before and after hydroxylamine treatment. The digestion was carried out for 5 h at 37°C in 50 mM potassium phosphate buffer (pH 7.0) in a final volume of 25 µL. Peptide mass fingerprints were recorded in reflector positive-ion mode (accelerating voltage 20 kV, grid voltage 73%, guide wire 0.002%, delay 200 ns) on a Voyager DE-STR MALDI-TOF mass spectrometer (PerSeptive-Applied Biosystems) equipped with a 337 nm nitrogen laser using a close external calibration covering the range 750-4000 Da. 1 µL of peptide solutions was mixed with 3 µL of 50% acetonitrile, 0.3% trifluoroacetic acid and 6 µL of saturated solution of µ-cyano-4-hydroxycinnamic acid in 30% acetonitrile, 0.3% trifluoroacetic acid. 1.3 µL of this premix was then deposited onto the sample plate and allowed to dry at room temperature.
Chemicals -CH 2 H 4 folate was a generous gift of Dr. Moser (Eprova). FAD, dUMP, DEPC and hydroxylamine were purchased from Sigma.
Crystallization and structure determinationProtein samples were stored in 0.1 M Tris-HCl (pH 8.5). Protein crystals were grown at 18°C from a 1:1 µL mixture of 10 mg/ml protein solution with 10% PEG 400, 0.1 M MgCl 2 , 18% isopropanol and 5% PEG MME 550. The best crystals were obtained for the protein incubated with 1 mM FAD before crystallization. For data collection, crystals were transferred to a cryo-solution consisting of 30% PEG 400, 0.1 M MgCl2, 18% isopropanol, 5% PEG MME 550 and subsequently flash-cooled in liquid nitrogen. Diffraction data were collected at 100K on the ID14-EH2 beam line (ESRF, Grenoble, France). These data were processed using XDS package (14) . The crystals belong to the P2 1 2 1 2 space group with predicted two molecules per asymmetric unit and a solvent content of 51%. Molecular replacement was done using the program Molrep (15) and coordinates of the previously solved crystal structure of TSCP (TM0449) from Thermotoga maritima (PDB code 1kq4, (3)). In the resulting model, the two monomers of ThyX had an R factor of 58.8% for data in the 20 Å to 4 Å range. However, by applying symmetry operations, the biologically active tetramer previously observed for TM0449 is reconstituted (3), indicating that this model is correct. This was further confirmed by automated refinement and rebuilding of the model using the program ARP/wARP (16) , which led to automatic construction of 83% of the model and significant improvement of the R free . The structure was refined using the program Refmac (17) and manually rebuilt with Turbo Frodo (18) . As some regions were found to adopt different conformations, NCS restraints were not used during refinement. The final model (the intact protein is made of 222 amino acids including the hexa-histidine tag) contains residues 1-35, 39-89, 124-216 for chain A and 1-88, 125-215 for chain B. In addition, two FAD and 247 water molecules have been built. All these residues are well defined in the 2Fo-Fc electron density map and fall within the allowed region of the Ramachandran plot, as defined by Procheck (19). Statistics for data collection and refinement are reported in Table  1 .
RESULTS
Structure of PBCV-1 ThyX -
The crystal structure of the PBCV-1 ThyX protein complexed to its FAD cofactor was solved by molecular replacement using the Thermotoga maritima TM0449 structure (hereafter TmThyX) as starting model and refined to 2.3 Å resolution (data acquisition and refinement statistics are presented in supplemental table 1). As shown in Figure 1A , the PBCV-1 ThyX monomer adopts the same hammerhead shark shaped structure as Tm and Mycobacterium tuberculosis (Mtb) ThyX with approximate dimensions 30×35×70 Å 3 (3, 20) . The monomer is made of a central α/β domain composed of a curved four-stranded anti-parallel β-sheet (β1, β2, β4, and β3) and six helices (α1, α2, α3, α6, α7 and α8) packed against the same face of the sheet. Two additional long α helices (α4 and α5) form a distinct domain on top of the core. The r.m.s.d. value between PBCV-1 and Tm or Mtb ThyX monomers is 1.5 Å or 1.95 Å, respectively (values calculated for 160-170 Cα atoms). The differences between these structures reside mainly in small variations in the orientation of the helices that are not in direct contact with the β−sheet of the central core domain (α1, α2, α8, α4 and α5).
Although, only two PBCV-1 ThyX monomers (chains A and B) are present in the asymmetric unit (r.m.s.d. between these two chains is 0.27 Å for all main chain atoms), a homotetramer similar to the one previously described for Tm and Mtb ThyX can be obtained by applying the space group symmetry operations (Fig. 1B, r. m.s.d. between the tetrameric forms of Tm and PBCV-1 ThyX is 3.81 Å for Cα atoms only) (3, 20) . The homotetramer has approximate dimensions of 50×60×85 Å 3 . As previously observed, the tetramer is mostly formed by stacking of helices from the core domains as well as by pairwise interaction of the long helices α4 and α5 that are detached from the core domain.
FAD binding mode -The purified PBCV-1 ThyX protein is characterized by a yellow colour, indicating that the oxidized form of the flavine cofactor remains tightly bound to this viral protein during all the purification steps (3, 20) . Similarly to other structures of ThyX proteins, the FAD cofactors lie in large clefts at the interface between the four monomers and adopt an elongated conformation. The FAD molecules are deeply buried since only 15% from each FAD molecule surface remains solvent accessible. This accessible region corresponds to the isoalloxazine (flavin) ring of the FMN moiety where the redox chemistry takes place. On the opposite side of the FAD cofactor, the ribityl and AMP parts are strongly fixed onto the protein and fully buried. Surprisingly, superposition of the Thermotoga maritima (Tm) and Mycobacterium tuberculosis (Mtb) structures of flavindependent thymidylate synthase ThyX onto the PBCV-1 ThyX-FAD complex shows that the FAD adenosine ring adopts a different conformation in the PBCV-1 enzyme (Figs.  1C, D) . In PBCV-1 ThyX, two adenosine moieties bound to two distinct monomers are stacked together (mean distance of 3.6 Å between adenosine rings) and sandwiched in between two histidine rings (H177 from chain A and B', distances of 4.1 Å and 3.5 Å, respectively), thus forming a four layered ring stack. In Tm and Mtb ThyX, the corresponding adenosines point away from each other and lie on the side chain from the residue directly following the RHR signature: H98 (Mtb ThyX) and I81 (Tm ThyX). In PBCV-1 ThyX, the pocket that is equivalent to the Mtb and Tm ThyX AMP binding site is blocked by the side chains from H83 from monomer A and E58, T171, R173 and D174 from monomer B. The phosphoribityl binding mode exhibits a high degree of similarity with previously described structures and hence will not be described here. The tricyclic isoalloxazine carries the reactive moiety of FAD. In the absence of bound dUMP, the isoalloxazine ring in PBCV-1 ThyX is solvent accessible on its si-face while the re-face packs onto the H53 side chain, involving this residue in hydrophobic packing interactions. In the Mtb and Tm ThyX structures, the ring of the corresponding histidine and the isoalloxazine ring are not stacked but bound in a perpendicular direction at the edge of this ring. Comparison of the residues homologous to H53 in these three enzymes shows that in PBCV-1 ThyX, helix α2, that precedes the loop bearing H53, has slipped along the helical axis by about 2.7 Å, resulting in a more buried position for H53 (Fig. 1D) .
In addition, the isoalloxazine pyrimidine ring makes five hydrogen bonds with residues originating from three different monomers (A, A' and B'). The interaction of the N η 1 atom from the invariant R78 residue, (corresponding to the first arginine residue of the RHR sequence motif, characteristic of ThyX proteins), with the O 2 atom of the FAD molecule is of interest from a catalytic point of view. The presence of a largely conserved positively charged residue near this part of the FAD was suggested to be functionally relevant either in modulating the redox potential of the co-factor or in stabilising the anionic form of the reduced flavin (21) . The four remaining hydrogen bonds are made by the S55 hydroxyl group (monomer B') with FAD N 1 , the E86 amide group (monomer A') with FAD O 2 as well as the Q85 Oε 2 and the E86 carbonyl oxygen (both from monomer A') with FAD N 3 (Fig. 1E) .
Identification of functionally important ThyX residues using a structure-based sequence alignment -In order to identify functionally important ThyX residues, we first performed a structure-based sequence alignment of a diverse set of ThyX proteins (Fig. 2) . A number of conserved ThyX residues have been previously characterized using site-directed mutagenesis approaches (7, 11, 20) . For instance, in Helicobacter pylori ThyX, mutation of the histidine residue equivalent to PBCV-1 ThyX H53 results in no detectable activity although the protein is folded, as it is still able to bind FAD (11) . In parallel, S88 (all residue numbering used hereafter refers to PBCV-1 ThyX) has been proposed to act as the nucleophile in the catalytic reaction, although in the reported ThyX structures this residue is never optimally located for a nucleophilic attack to occur at position 6 of dUMP (3, 20) .
Amino acid residues involved in the binding of FAD or dUMP in ThyX have been identified by crystallographic analyses of ternary complexes (indicated by circles and squares in Fig. 2, (3,20) but little is known about the residues implicated in NADPH or CH 2 H 4 folate binding.
In this work we analyzed the role of several conserved residues in ThyX catalysis: H53, H79, R90, H177, R182 and E190 (indicated by arrows in Fig. 2 ). Except for H53, the role of these residues in ThyX catalysis and/or substrate binding has not been investigated prior to this study.
Mutational analysis of conserved residues of PBCV-1 ThyX -Several site-directed mutants of the above residues were constructed and their roles in ThyX catalysis were studied (Table 1 ). Complementation tests indicated that, with the exception of the H79Q and H177Q substitutions, all mutants analyzed did not confer thymidine-independent growth to an E. coli strain lacking thymidylate synthase ThyA, thus emphasizing their importance for ThyX activity. The H53Q and H53K mutant strains did not produce soluble protein for biochemical analyses, and the lack of complementation could simply result from improper folding of the protein. All other mutant proteins produced comparable amounts of soluble protein after induction (data not shown). Therefore, the lack of functional complementation suggests that these residues play important roles in ThyX catalysis and/or substrate binding.
To investigate the biochemical basis for the observed loss of complementation activity, the soluble PBCV-1 mutant proteins were expressed and purified. As expected, the complementing mutant proteins, H79Q and H177Q, were still active in NADPH oxidation and deprotonation assays (Table 2 ). However, both purified histidine mutants were instable and their k cat /K m values changed simultaneously for all three substrates. This could be explained by the role played by both residues in FAD binding. First, the H79 side chain packs against the FAD ribityl part and is also hydrogen bonded to the phosphate group of the AMP moiety (Fig. 1C) . Second, as mentioned above, the H177 side chain is involved in binding of the FAD adenine base in a four-layer stacking. The R90A mutant has lost 44% of its oxidation activity and shows no measurable deprotonation activity. On the basis of the Thermotoga maritima ThyX structural data, the region containing R90 participates in dUMP binding (3) . Together with our earlier demonstration that dUMP binding is necessary for NADPH oxidation by PBCV-1 ThyX (see supplemental figure 1 ) this provides a feasible explanation for its decreased oxidation activity. 
ThyX activity is inhibited by DEPC treatment -
As we failed to purify the H53Q and H53K mutant proteins in soluble form, we used chemical modification by diethylpyrocarbonate (DEPC) to further investigate the proposed catalytic role(s) of histidine residues (11). For these experiments, the deprotonation activity of PBCV-1 ThyX wild type protein was measured before and after DEPC treatment. The DEPC treatment decreased ThyX deprotonation activity at least 20-fold and was partially reversible with hydroxylamine (NH 2 OH) treatment (see below), indicating that the DEPC-modified histidine residues are implicated in the ThyX catalytic mechanism.
More detailed titration experiments with the DEPC-treated enzyme in the presence of varied substrates were performed to further investigate the effect of the chemical modification ( Fig. 4A-C MALDI-TOF mass spectrometry after tryptic cleavage was performed in order to identify the modified residue(s). As this derivatization is quite unstable, depending on the conditions (optimum pH 6.0-7.0) (22) , all experiments were performed in phosphate buffer pH 7.0 as quickly as possible, although these conditions were not optimal for trypsin proteolysis and mass spectrometry (no desalting prior to data acquisition). Peptide mass fingerprints clearly showed that three peptides, namely [D174-R182], [H53-K67] (Fig. 4D ) and [Y94-R104] (data not shown), exhibited a 72 Da mass increase after DEPC treatment, in agreement with the derivatization of a histidine residue into carbethoxyhistidine. All of the "fingerprints" contain only one histidine residue, respectively in positions 53, 101 and 177 (modified histidines are indicated in Fig.  2 ). DEPC has been reported to occasionally react with other nucleophilic groups (principally hydroxyl groups, e. g. tyrosine). It has been reported that the effect of DEPC on histidine and tyrosine can be reversed by mild treatment with hydroxylamine, but the reversion is much more rapid in the case of the DEPC-derivatized histidine (13) . Thus, in order to unambiguously assign the mass shift to the specific derivatization of His residues, we have investigated the effect of hydroxylamine on DEPC-treated PBCV-1 ThyX. Figure 4D (spectrum 3) shows that the tryptic profile of DEPC-treated PBCV-1 ThyX rapidly returns to the pattern of the control sample after treatment with hydroxylamine. In addition, the mass spectrum of the ThyX protein treated with only hydroxylamine was identical to the one of a control sample (data not shown), indicating that no modification artefact was induced. We can thus conclude that three histidine residues have been modified: H53, H101 and H177. Of these residues, H101 is not conserved (Fig. 2) (Fig. 5A-C) . For all substrate couples, our data unambiguously demonstrated a set of several converging lines, indicative of a sequential kinetic mechanism, different from what has been reported for C. trachomatis ThyX (7). These findings are compatible with our earlier proposal indicating that ThyX catalysis proceeds via formation of ternary complexes of two substrates bound to the enzyme at the same time. Considering that CH 2 H 4 folate inhibits NADPH binding /oxidation in a competitive way, the binding sites for these two substrates could overlap. Consequently, formation of a quaternary complex where all three substrates are simultaneously bound to the enzyme seems unlikely.
DISCUSSION
To date no structural information is available on the binding modes of ThyX with the substrates NADPH or tetrahydrofolate and so far our extensive efforts to obtain quality diffracting crystals of PBCV-1 ThyX complexed to its different substrates did not provide exploitable information.
Since our kinetic experiments are indicative for simultaneous binding of dUMP and NAD(P)H, we attempted to model the ternary complex with NAD(P)H using the complexes of Tm and Mtb ThyX enzymes bound to FAD and dUMP (3, 20) to position dUMP into the active site of PBCV-1 ThyX. As shown in Figure 2 , all residues involved in dUMP binding (squares and circles) are conserved between PBCV-1, Tm and Mtb ThyX. Only minor side chain adjustments of residues E86 and R155 are needed to accommodate dUMP in the PBCV-1 ThyX active site in the same configuration as for the Tm and Mtb enzymes. In these complexes the uracil base stacks onto the central ring of the FAD isoalloxazine moiety and the ribose phosphate is clamped between helix α3 and the substrate binding loop (residues 86-97). In our PBCV-1 ThyX-FAD complex, this loop is mostly disordered and the hydroxyl group of the putative S88 catalytic nucleophile (11) is 8 to 9Å away from dUMP. In the Tm ThyX apo-structure this loop is equally unstructured while becoming folded upon interaction with dUMP. Hence, upon substrate binding to PBCV-1 ThyX, this loop could become ordered and bring the S88 hydroxyl group in closer contact to the substrates.
In order to fit NADPH into the PBCV-1 ThyX FAD complex we have searched within the Protein Data Bank for all the nonredundant structures describing ternary protein complexes with NAD(P)H and FAD or FMN. We identified 16 of these complexes that could be grouped into three different binding clusters. In the first cluster (grouping nine complexes, best exemplified by glutathione reductase (23), the nicotinamide ring from the NAD(P)H stacks onto the central isoalloxazine ring in a way that is very similar to the binding mode of dUMP complexed with FAD-ThyX. In the second binding mode (1 complex: 2,4-dienoyl-CoA reductase (24) , the plane of the nicotinamide ring lies perpendicular to the FAD isoalloxazine pyrimidine ring and occupies the same position as the ribose in the dUMP-ThyX complex. In complexes of the third cluster (grouping 6 cases) FAD (or FMN) is more than 10Å away from NAD(P)H. None of these modes is fully compatible with our experimental data. However, our biochemical data show that NAD(P)H binding and/or oxidation is substantially increased by the presence of dUMP, suggesting that dUMP binding re-orients NADPH at the active site to optimize electron transfer. Structural data with bound NADPH analogs (with or without dUMP) will be required to understand the NADPH binding mode of ThyX proteins.
Our mutagenesis results have identified residues that are important for NAD(P)H oxidation ( Table 2 ). These residues have been mapped in Figure 6 . Apart from H53, mutation of additional ThyX residues provokes moderate (R90A and R182A) to drastic effects (E190G) on NAD(P)H oxidation activity. These three purified mutant proteins still bind FAD, indicating that the tetramer was assembled correctly. In consequence, the loss of NAD(P)H oxidation might either reflect a decreased affinity for NAD(P)H and/or dUMP (the latter being necessary for PBCV-1 ThyX NAD(P)H oxidase activity) or a deleterious effect on catalytic activity. The side chains of the strictly conserved arginine residues at positions 90 and 182 are hydrogen bonded to the dUMP uracil base. Their substitution by alanine should therefore reduce ThyX affinity for dUMP. The role of E190 is more complex. In the structures of Tm and Mtb ThyX, its carboxylate is hydrogen bonding with S86 (Mtb ThyX) or R105 (Tm ThyX). It is only poorly solvent accessible in the ternary ThyX-FAD-dUMP complex and is unlikely to be directly interacting with NAD(P)H. The complete loss of activity of the E190G is probably due to a local destabilization of the active site. Despite their partial NADPH oxidation activity no in vivo complementation is observed with the R90A and R182A mutants, due to their lack of protonation activity. From our structural model and in agreement with the proposal of Agrawal et al. (4) , we conclude that R90 and R182 are positioned in a way that they could be involved both in CH 2 H 4 folate and dUMP binding or methyl transfer to dUMP, explaining why they fail to complement in vivo.
The PBCV-1 ThyX H53Q and H53K mutant strains did not produce soluble protein for biochemical analyses, and the lack of complementation could simply result from improper folding of the protein or be due to the more buried position of the histidine side chain (Fig. 1D) . Site-directed mutagenesis and activity measurements on the corresponding histidine residue in Helicobacter pylori ThyX (H48; (11)) as well as chemical modification studies on PBCV-1 ThyX (Fig. 4D) indicate that this histidine side chain has a role in NADPH binding and/or oxidation. This could either be a direct effect or, alternatively, chemical modification of this residue could reorient FAD at the active site influencing NADPH binding. Note also that in Tm and Mtb ThyX, analogous histidine residue is in close vicinity of the redox active N5 atom of the FAD molecule suggesting that it could act as proton donor and/or acceptor as observed in most flavin-dependent enzymes (21) . In the actual PBCV-1 ThyX structure, H53 is not ideally positioned to exert this role. However, H53 reacts readily with DEPC, indicating that this residue is accessible and undergoes structural alterations. In agreement with the helix α2 sliding observed between PBCV-1 and Tm or MtB ThyX structures (Fig. 1D) , a possible conformational change, possibly induced by substrate binding, might bring the H53 Nε2 atom within a more favourable position to abstract (or receive) a proton from the isoalloxazine N5.
Our site-directed mutagenesis, chemical modification and structural data have provided new insight into the active site of ThyX proteins. Whereas our kinetic data indicate formation of a ternary NADPH/dUMP complex (Fig. 7) , an earlier study has proposed a ping-pong mechanism implicating the formation of a methyl enzyme intermediate during turnover of C. trachomatis ThyX (7). It is of note that we have been unable to detect the proposed covalent intermediate using either radioactively marked 14 CH 2 H 4 folate or mass spectrometric analyses for either PBCV-1 or C. trachomatis ThyX proteins (data not shown). The reasons for these experimental discrepancies are currently unknown. However, double reciprocal plots apparently suggesting a ping-pong mechanism have also been measured for Lactobacillus casei ThyA protein (8) , although all other kinetic data supported a sequential mechanism. Moreover, the order of substrate binding of ThyA proteins has been reported to depend on buffer composition used in the experiments (1). Additional experimental evidence is required to elucidate the role of the proposed ternary complexes of PBCV-1 ThyX in catalysis. Figure 6 : Mapping of the ThyX residues involved in catalysis. PBCV-1 and Mtb ThyX are coloured yellow and grey, respectively. PBCV-1 ThyX residues whose mutation completely affects NAD(P)H oxidation or methyl transfer are represented in red and orange, respectively. The two positions H79 and H177 for which substitution by lysine or glutamine has either dramatic or no effect on ThyX activity are coloured in light blue. The bromine atom from BrdUMP is coloured in purple. For clarity, only PBCV-1 ThyX numbering is indicated. Phosphorous atoms from FAD and BrdUMP are coloured in black. Figure 7 : Cleland plot for the proposed catalytic mechanism of ThyX proteins. Note that the order in which products are released from the active site has not been investigated in detail. Values in parentheses are for the highest resolution shell. dUMP NADPH NADP
